|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Double-stranded DNA in exosomes: a novel biomarker in cancer detection显示文摘 | Basant Kumar Thakur Haiying Zhang Annette Becker Irina Matei Yujie Huang Bruno Costa-Silva Yan Zheng Ayuko Hoshino Helene Brazier Jenny Xiang Caitlin Williams Ruth Rodriguez-Barrueco Jose M Silva Weijia Zhang Stephen Hearn Olivier Elemento Navid Paknejad Katia Manova-Todorova Karl Welte Jacqueline Bromberg Hector Peinado David Lyden | 2014 | Cell Research2014，24，6： | 98 |
| 2 | Recent advances in gastric cancer early diagnosis显示文摘Gastric cancer(GC) remains an important cause of cancer death worldwide with a high mortality rate due to the fact that the majority of GC cases are diagnosed at an advanced stage when the prognosis is poor and the treatment options are limited. Unfortunately, the existing circulating biomarkers for GC diagnosis and prognosis display low sensitivity and specificity and the GC diagnosis is based only on the invasive procedures such as upper digestive endoscopy. There is a huge need for less invasive or non-invasive tests but also highly specific biomarkers in case of GC. Body fluids such as peripheral blood, urine or saliva,stomach wash/gastric juice could be a source of specific biomarkers, providing important data for screening and diagnosis in GC. This review summarized the recently discovered circulating molecules such as microRNAs, long non-coding RNAs, circular RNAs, which hold the promise to develop new strategies for early diagnosis of GC. | Laura Necula Lilia Matei Denisa Dragu Ana I Neagu Cristina Mambet Saviana Nedeianu Coralia Bleotu Carmen C Diaconu Mihaela Chivu-Economescu | 2019 | World Journal of Gastroenterology2019，25，17： | 70 |
| 3 | c-Met targeted therapy of cholangiocarcinoma显示文摘Cholangiocarcinoma continues to be a challenging disease to treat. Systemic therapy is used in unresectable disease, disease progression after surgery, and in the palliative setting. Unfortunately, results of multiple phase Ⅱ trials have rarely yielded positive results. As data on the molecular carcinogenesis of cholangiocarcinoma is developing, we are more able to understand the disease process and can use this understanding to create unique targeted therapies. We reviewed the role of c-Met/ hepatocyte growth factor (HGF) in the development of cholangiocarcinoma. Furthermore, we explored the use of the c-Met guided cascade as a target to treat cholangiocarcinoma. We reviewed the current use and options for future development of c-Met agents to treat this disease. | Matei P Socoteanu Frank Mott Gianfranco Alpini Arthur E Frankel | 2008 | World Journal of Gastroenterology2008，14，19： | 16 |
| 4 | New therapeutic options opened by the molecular classification of gastric cancer显示文摘Gastric cancer(GC) is one of the most lethal and aggressive cancers, being the third cause of cancer related death worldwide. Even with radical gastrectomy and the latest generation of molecular chemotherapeutics, the numbers of recurrence and mortality remains high. This is due to its biological heterogeneity based on the interaction between multiple factors, from genomic to environmental factors, diet or infections with various pathogens. Therefore, understanding the molecular characteristics at a genomic level is critical to develop new treatment strategies. Recent advances in GC molecular classification provide the unique opportunity to improve GC therapy by exploiting the biomarkers and developing novel targeted therapy specific to each subtype. This article highlights the molecular characteristics of each subtype of gastric cancer that could be considered in shaping a therapeutic decision, and also presents the completed and ongoing clinical trials addressed to those targets. The implementation of the novel molecular classification system will allow a preliminary patient selection for clinical trials, a mandatory issue if it is desired to test the efficacy of a certain inhibitor to the given target. This will represent a substantial advance as well as a powerful tool for targeted therapy. Nevertheless, translating the scientific results into new personalized treatment opportunities is needed in order to improve clinical care, the survival and quality of life of patients with GC. | Mihaela Chivu-Economescu Lilia Matei Laura G Necula Denisa L Dragu Coralia Bleotu Carmen C Diaconu | 2018 | World Journal of Gastroenterology2018，24，18： | 14 |
| 5 | A view of cloud computing显示文摘 | Michael Armbrust Armando Fox Rean Griffith Anthony D. Joseph Randy Katz Andy Konwinski Gunho Lee David Patterson Ariel Rabkin Ion Stoica Matei Zaharia | 2010 | Communications of the ACM2010，，4： | 13 |
| 6 | Bleeding Dieulafoy's-like lesions of the gut identified by capsule endoscopy显示文摘Dieulafoy's-like lesions (DLs-like) represent a cause of obscure gastrointestinal bleeding, enteroscopy being the main diagnostic and therapeutic procedure. Frequently, more than one enteroscopy is needed to identify the bleeding vessel. In our practice, video capsule endoscopy (VCE) identified and guided therapy in four cases of DLs-like; three of them were localized on the small bowel. We report, for the first time, a diagnosis of colonic DL-like performed by colon capsule endoscopy. Two patients presented with severe cardiovascular disorders, being hemodynamically unstable during VCE examination. Based on the VCE findings, only one invasive therapeutic procedure per patient was necessary to achieve hemostasis. VCE and enteroscopy may be regarded as complementary procedures in patients with gut DLs-like. | Lidia Ciobanu Oliviu Pascu Brindusa Diaconu Daniela Matei Cristina Pojoga Marcel Tantu | 2013 | World Journal of Gastroenterology2013，19，29： | 8 |
| 7 | A view of cloud computing显示文摘 | Michael Armbrust Armando Fox Rean Griffith Anthony D. Joseph Randy Katz Andy Konwinski Gunho Lee David Patterson Ariel Rabkin Ion Stoica Matei Zaharia | 2010 | Communications of the ACM2010，，4： | 5 |
| 8 | Hard carbon derived from coconut shells,walnut shells,and corn silk biomass waste exhibiting high capacity for Na-ion batteries显示文摘In recent years,hard carbon materials have gained significant interest as anode materials for Na-ion batteries.Biomass waste is considered one of the most interesting,renewable,available,and cost-effective precursor to obtain hard carbon(HC);however,HC properties must be finely tuned to achieve performance comparable to those provided by Li-ion batteries.In this work,three biomass wastes(coconut shells,walnut shells,and corn silk) were evaluated as potential precursors for HC preparation involving a pyrolysis process and subsequent acid washing to remove the inorganic impurities.All obtained materials exhibited low and similar specific surface areas(<10 m^(2)·g^(-1)), but they presented different structures and surface functionalities.The walnut shell HC possessed a lower amount of inorganic impurities and oxygen-based functional groups compared to the coconut shell and corn silk HCs,leading to higher initial coulombic efficiency(iCE).The structural organization was higher in the case of the walnut shell HC,while the corn silk HC revealed a heterogeneous structure combining both highly disordered carbon and localized graphitized domains.All HCs delivered high initial reversible capacities between 293 and 315 mAh g^(-1) at 50 mA g^(-1) current rate,which remained rather stable during long-term cycling.The best capacity(293 mAh g^(-1) after 100 charge/discharge cycles) and highest capacity retention(93%) was achieved in walnut HCs in half-cells,which could be associated with its higher sp2 C content,better organized structure,and fewer impurities.An 'adsorption-insertion' Na storage mechanism is suggested based on several techniques.The walnut HCs exhibited an attractive energy density of 279 Wh/kg when tested in full cells. | Cristina Nita Biao Zhang Joseph Dentzer Camélia Matei Ghimbeu | 2021 | Journal of Energy Chemistry2021，30，7： | 4 |
| 9 | Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients显示文摘 | Teerha Piratvisuth Patrick Marcellin Matei Popescu Hans-Peter Kapprell Vivien Rothe Zhi-Meng Lu | 2013 | Hepatology International2013，，2： | 2 |
| 10 | Murine models based on acute myeloid leukemia-initiating stem cells xenografting显示文摘Acute myeloid leukemia(AML) is an aggressive malignant disease defined by abnormal expansion of myeloid blasts. Despite recent advances in understanding AML pathogenesis and identifying their molecular subtypes based on somatic mutations, AML is still characterized by poor outcomes, with a 5-year survival rate of only 30%-40%, the majority of the patients dying due to AML relapse. Leukemia stem cells(LSC) are considered to be at the root of chemotherapeutic resistance and AML relapse. Although numerous studies have tried to better characterize LSCs in terms of surface and molecular markers, a specific marker of LSC has not been found, and still the most universally accepted phenotypic signature remains the surface antigens CD34+CD38- that is shared with normal hematopoietic stem cells. Animal models provides the means to investigate the factors responsible for leukemic transformation, the intrinsic differences between secondary post-myeloproliferative neoplasm AML and de novo AML, especially the signaling pathways involved in inflammation and hematopoiesis. However, AML proved to be one of the hematological malignancies that is difficult to engraft even in the most immunodeficient mice strains, and numerous ongoing attempts are focused to develop 'humanized mice' that can support the engraftment of LSC. This present review is aiming to in-troduce the field of AML pathogenesis and the concept of LSC, to present the current knowledge on leukemic blasts surface markers and recent attempts to develop best AML animal models. | Cristina Mambet Mihaela Chivu-Economescu Lilia Matei Laura Georgiana Necula Denisa Laura Dragu Coralia Bleotu Carmen Cristina Diaconu | 2018 | World Journal of Stem Cells2018，10，6： | 2 |
| 11 | Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a显示文摘 | Patrick Marcellin Ferruccio Bonino George K.K. Lau Patrizia Farci Cihan Yurdaydin Teerha Piratvisuth Rui Jin Selim Gurel Zhi-Meng Lu Jian Wu Matei Popescu Stephanos Hadziyannis | 2009 | Gastroenterology2009，，7： | 2 |
| 12 | Estimation of nonlinear errors-in-variables models for computer vision applications 显示文摘 | Matei B C Meer P | 2006 | IEEE Transactions on Pattern Analysis and Machine Intelligence2006，28，10： | 1 |
| 13 | First eigenvalue for the p-Laplace operator显示文摘 | MATEI A M | 2000 | Nonlinear Anal Ser A: Theory Methods2000，39，8： | 1 |
| 14 | Laser Photoacoustic Spectroscopy: Principles, Instrumentation, and Characterization 显示文摘 | Dumitras D C Dutu D C Matei C | 2007 | Journal of Optoelectronics and Advanced Materials2007，9，12： | 1 |
| 15 | A view of cloud computing显示文摘 | Michael Armbrust Armando Fox Rean Griffith Anthony D. Joseph Randy Katz Andy Konwinski Gunho Lee David Patterson Ariel Rabkin Ion Stoica Matei Zaharia | 2010 | Communications of the ACM2010，，4： | 1 |
| 16 | Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a显示文摘 | Patrick Marcellin Ferruccio Bonino George K.K. Lau Patrizia Farci Cihan Yurdaydin Teerha Piratvisuth Rui Jin Selim Gurel Zhi-Meng Lu Jian Wu Matei Popescu Stephanos Hadziyannis | 2009 | Gastroenterology2009，，7： | 1 |
| 17 | Id1suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation显示文摘 | Papaspyridonos M Matei I Huang Y | 2015 | Nat Commun2015，29，6： | 1 |
| 18 | Anti HIV activity of defective cyanovirin-N mutants is restored by dimerization显示文摘 | Matei Elena Zheng Andrew Furey Williamet | 2010 | The Journal of Biological Chemistry2010，285，13： | 1 |
| 19 | A machine-vision system for iris recognition显示文摘 | Richard P. Wildes Jane C. Asmuth Gilbert L. Green Steven C. Hsu Raymond J. Kolczynski James R. Matey Sterling E. McBride | 1996 | Machine Vision and Applications1996，，1： | 1 |
| 20 | Sustained response to peginterferon alfa-2a (40?kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B显示文摘 | Teerha Piratvisuth George Lau You-Chen Chao Rui Jin Anuchit Chutaputti Q.-B. Zhang Tawesak Tanwandee Peter Button Matei Popescu | 2008 | Hepatology International2008，，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员